awmsg logo



colecalciferol (Fultium-D3®)


Reference No. 1499

Publication date:
13/11/2012


Last review date:
30/09/2016

Appraisal information

colecalciferol (Fultium-D3®) 800 units capsule


Company: Internis Pharmaceuticals Ltd
BNF category: Nutrition and blood
NMG meeting date: 05/09/2012
AWMSG meeting date: 17/10/2012
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 3612
Ministerial ratification: 09/11/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Colecalciferol (Fultium-D3®) is recommended as an option for use within NHS Wales for the prevention and treatment of vitamin D deficiency and as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency. Fultium-D3® is indicated in adults, the elderly and adolescents.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download